RELIEF THERAPEUTICS Holding SA RLF-CH:Swiss Exchange

*Data is delayed | CHF
Last | 5:31 PM CEST
0.223quote price arrow up+0.011 (+5.19%)
Volume
17,350,507
52 week range
0.04 - 0.80

...

Loading . . .
  • Open0.225
  • Day High0.234
  • Day Low0.215
  • Prev Close0.212
  • 52 Week High0.80
  • 52 Week High Date08/07/20
  • 52 Week Low0.04
  • 52 Week Low Date08/03/20

Key Stats

  • Market Cap750.89M
  • Shares Out3,246.73M
  • 10 Day Average Volume18.9M
  • Dividend-
  • Dividend Yield-
  • Beta-0.06
  • YTD % Change-14.5

KEY STATS

  • Open0.225
  • Day High0.234
  • Day Low0.215
  • Prev Close0.212
  • 52 Week High0.80
  • 52 Week High Date08/07/20
  • 52 Week Low0.04
  • 52 Week Low Date08/03/20
  • Market Cap750.89M
  • Shares Out3,246.73M
  • 10 Day Average Volume18.9M
  • Dividend-
  • Dividend Yield-
  • Beta-0.06
  • YTD % Change-14.5

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On RELIEF THERAPEUTICS Holding SA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong...
Raghuram Selvaraju PHD
Chairman
Taneli Jouhikainen M.D.
Chief Operating Officer
Jack Weinstein
Chief Financial Officer
Address
Fondation EIP
Batiment F2/F3, Avenue de Secheron 15
Geneve
1202
Switzerland